PeptideStack
5.2kquestions
20kanswers
220users

My liraglutide vial sat at 37 °C for three days — is testing worth it before use?

Asked 6 May 2026Modified 40 days agoViewed 4.8k times
4

The particulars: liraglutide · 37 °C · three days.

I would like to define my thresholds before I have a result, for obvious reasons.

I want a plan with explicit stopping rules, not just steps.

What does a sensible plan look like, and what are the decision points?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
shareeditfollowflag
EB
askedelke_brunner17k286 May 2026

5 Answers

Accepted answer first, then by votes
61

Accepted answer

Three days at 37 °C is about 28 refrigerated days of equivalent exposure. 37 °C is 32 kelvin above the 5 °C middle of a 2–8 °C refrigerator. The ten-degree rule of thumb — degradation rate roughly doubling per 10 K — makes that about 9.2 times the refrigerated rate, which is an order-of-magnitude statement and not a shelf life. At 28 equivalent days a test is more likely to reassure you than to tell you something, which is a legitimate reason to run it and a poor reason to expect a finding. Either way, record the three days and the temperature now, while you still know them; an excursion you did not write down is an excursion you cannot interpret later.

The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

Degradation pathway by condition

PathwayDominant whenDetected by
DeamidationSolution, neutral to alkaline pHRP-HPLC, +1 Da on MS
OxidationLight, trace metals, peroxidesRP-HPLC, +16 Da on MS
HydrolysisSolution, extremes of pHRP-HPLC, fragment masses
AggregationAgitation, interfaces, high concentrationSEC, visual haze; often invisible on RP-HPLC
Freeze-concentration damageFreeze-thaw of buffered solutionSEC, loss of recovered content

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

A cold pack tells you nothing about the eleven days before the last one.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
JF
answered · acceptedjuliette_farnese13k3827 May 2026
Adding for future readers: the domestic leg after delivery is the part you control. – coldpack_88 5 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
24

Answering this needs the transit duration and the ambient temperature, and then the arithmetic is straightforward.

That is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

Mechanically, a pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.

Nothing here is medical advice, and research-use compounds are not approved for human use.

The domestic leg is the part you control. Refrigerate it promptly.

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25821 May 2026
17

Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Lyophilised tolerates the lane. That is the answer for almost every order.

shareimprove this answerflag
ZM
answeredzainab_mustafa21k2714 May 2026
14

The part that matters: if temperature history matters to you, buy a data logger. It is the only way to know.

Once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
HP
answeredh_pergande71k1588 May 2026
11

The relevant physics is latent heat: a phase-change pack holds temperature only while it is changing phase, and once it has melted it is a warm mass.

Asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

A liquefied pack is expected. It is not evidence of a problem.

shareimprove this answerflag
TM
answeredtobias_maartens171k35820 Jun 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.